Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer
Clinical trial NCT06904300 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06904300
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-15
- Primary completion
- 2028-04-30
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.